Education
About Us
Working with TipRanks
Follow Us
Conley Chee Insider Profile
4 Followers
Conley Chee, President & CEO, Director at Syros Pharmaceuticals, holds 0.00 shares in Syros Pharmaceuticals (Ticker: SYRS). Most recently, Conley Chee Sold $134,797 shares of Syros Pharmaceuticals on Nov 20, 2024 for an estimated value of 25.61K.
Conley Chee Syros Pharmaceuticals (SYRS)President & CEO, Director
Syros Pharmaceuticals (SYRS)
President & CEO, Director
Ranked #54,828 out of 100,956 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-4.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Conley Chee does not currently own shares as a corporate insider.
A breakdown of Conley Chee's holdings
Insider Roles
President & CEO, Director
Roles that Conley Chee holds in companies
Most Profitable Insider Trade
The most profitable trade made by Conley Chee
Conley Chee's Trading History
List of latest transactions for each holding click on a transaction to see Conley Chee's performance on stock
You May Also Like
Conley Chee insider profile FAQ
What is the percentage of profitable transactions made by Conley Chee?
The percentage of profitable transactions made by Conley Chee is 50%.
What is the average return per transaction made by Conley Chee?
The average return per transaction made by Conley Chee is -4.70%.
What stocks does Conley Chee hold?
Conley Chee holds: SYRS stocks.
What was Conley Chee’s latest transaction?
Conley Chee latest transaction was an Informative Sell of $25.61K.
What was Conley Chee's most profitable transaction?
Conley Chee’s most profitable transaction was an Informative Sell of SYRS stock on November 20, 2024. The return on the trade was 72.00%.
What is Conley Chee's role in Syros Pharmaceuticals?
Conley Chee's role in Syros Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.